Patients and their providers rely on these prescription drugs for treating injury and managing illness. Yet the drug companies and their shareholders have been treating America’s patients and providers like a piggybank.
News
Latest
The Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies today held a hearing to review what programs and strategies are working to address the opioid epidemic and where to focus future funding.
The House Education and Labor Committee’s Subcommittee on Workforce Protections yesterday held a hearing on protecting health care and social service workers from violence in the workplace.
The Centers for Medicare & Medicaid Services today updated its overall hospital quality star ratings at Hospital Compare and proposed future changes to the star ratings methodology in response to stakeholder feedback.
CMS has extended the deadline for hospitals participating in the Inpatient Quality Reporting and/or Promoting Interoperability Programs to submit data to receive a full payment update in fiscal year 2020.
The Centers for Medicare & Medicaid Services today published answers to frequently asked questions about Section 1332 State Relief and Empowerment Waiver pass-through funding.
Rep. Pramila Jayapal, D-Wash., today introduced the Medicare for All Act, legislation that would establish a national health insurance program to provide universal coverage to U.S. residents.
A new AHA infographic highlights the timeline for post-acute care reforms under the Improving Medicare Post-Acute Care Transformation Act of 2014.
An estimated 29.7 million U.S. residents, or 9.2 percent, lacked health insurance when surveyed in the first nine months of 2018, according to preliminary data released today.
Food and Drug Administration Commissioner Scott Gottlieb, M.D., yesterday announced the agency’s 2019 agenda to address the opioid epidemic.
The Senate Finance Committee today held the second in a planned series of bipartisan hearings on high prescription drug prices, which featured executives from drug companies AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck, Pfizer and Sanofi.
The House of Representatives last night passed by voice vote bipartisan legislation to reauthorize the national network of Poison Control Centers.
The FDA, CDC and CMS today launched the Tri-Agency Task Force for Emergency Diagnostics, which will work to rapidly develop and deploy diagnostic tests to clinical and public laboratories in an emergency.
Hospitals participating in the Inpatient Quality Reporting and/or Promoting Interoperability Programs must submit data by Feb. 28 to receive a full payment update in fiscal year 2020.
The Schwartz Center for Compassionate Healthcare will hold its 2019 Compassion in Action Healthcare Conference Sept. 8-10 in Boston.
The Centers for Medicare & Medicaid Services will host a Special Open Door Forum Feb. 26 at 2 p.m. ET on its proposed rule to promote electronic health information exchange.
The Centers for Medicare & Medicaid Services has posted answers to
A treatment protocol to prevent Methicillin-resistant Staphylococcus aureus infections after hospital discharge in patients known to carry the bacteria on their body reduced MRSA infections by 30 percent more than education alone, according to a study funded by the Agency for Healthcare Research and Quality and reported this month in the New England Journal of Medicine.
The U.S. Department of Agriculture and Department of Health and Human Services will partner to create addiction recovery transitional housing in rural communities, the agencies announced recently.
Get the ball rolling today by starting a conversation with your board about your vision, role and purpose in the community.